Report
EUR 551.94 For Business Accounts Only

The Bull Is Dead, Long Live The Bull - (GMR Weekly Notes - 2019 Outlooks - 2 Jan 2019)

Markets:
Stocks: Pfizer (PFE); Eli Lilly (LLY); AbbVie (ABBV); Nexstar Media (NXST); Amazon (AMZN); Alibaba (BABA); JD.com (JD); Triton International (TRTN); Healthcare Sector ETF (XLV)
Forex: EURGBP; Dollar Index (DXY); GBPJPY
Rates: 2s/10s; 5s/30s; EDZ9
Underlyings
2 SISTERS FOOD GROUP LTD

AbbVie Inc.

AbbVie is a research-based biopharmaceutical company. The company's products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. The company also has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health.

Alibaba Group Holding Ltd. Sponsored ADR

Amazon.com Inc.

Amazon.com serves consumers through its online and physical stores. The company also manufactures and sells electronic devices, including Kindle, Fire tablet, Fire TV, Echo, and Ring, and the company develops and produces media content. The company operates customer service centers and provides programs that enable sellers to grow their businesses, sell their products in its stores, and fulfill orders through the company The company serves developers and enterprises of various sizes, including start-ups, government agencies, and academic institutions, through its Amazon Web Services segment, which provides a set of global compute, storage, database, and other service offerings. The company also provides services, such as advertising.

Eli Lilly and Company

Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. The company's human pharmaceutical products include: diabetes and other endocrinology products, immunology products, neuroscience products, oncology products, and other products. The company's diabetes and other endocrinology products include: Baqsimi? and Basaglar?. The company's immunology products include: Olumiant? and Taltz?. The company's neuroscience products include: Cymbalta? and Emgality?. The company's oncology products include: Alimta?, Cyramza?, Erbitux? and Verzenio?. The company's other products include: Cialis?.

JD.com Inc. Sponsored ADR Class A

Nexstar Media Group Inc. Class A

Nexstar Media Group is a television broadcasting and digital media company focused on the acquisition, development and operation of television stations and interactive community websites and digital media services. The stations provide over-the-air programming. This programming includes programs produced by networks with which the stations are affiliated; programs that the stations produce; and first-run and rerun syndicated programs that the stations acquire. The company's digital media businesses provide digital publishing and content management platform, digital video advertising platform, social media advertising platform and other digital media solutions to media publishers and advertisers.

Pfizer Inc.

Pfizer is a research-based biopharmaceutical company. The company is engaged in discovering, developing, manufacturing and distributing of healthcare products, including medicines and vaccines. The company manages its commercial operations through three businesses: Pfizer Biopharmaceuticals Group, which includes Oncology, Inflammation and Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine business units, as well as a hospital business unit; Upjohn, which includes the company's solid oral dose brands such as Lyrica, Lipitor, Norvasc, Celebrex, Viagra, and certain generic medicines; and Consumer Healthcare, which is an over-the-counter medicines business.

Provider
Global Market Research
Global Market Research

Global Market Research provide quantitative, algorithm-based research to institutional investors in the Equity, FX, Rate, Commodity and Blockchain markets.   GMR provide significant value to our wide range of clients in four distinct ways:

  • Translate broad Macro ideas into actionable Price Strategy;
  • Apply the GMR proprietary method as an independent filter for client-driven ideas;
  • Utilize GMR's unique algorithm to identify markets with potential for major price shock; 
  • Bespoke Analysis.

GMR regularly publish four specialized subscription reports: MACRO Technicals® focuses on the major USD crosses, US Treasury yields and Equity markets. GMR Weekly Notes® identifies a Top 10 list of risk/reward opportunities across asset classes. Petro-Technicals® covers Crude Oil and Natural Gas markets; Bitcoin Technicals® focuses on blockchain technology.

Analysts
William Basa

Other Reports on these Companies
Other Reports from Global Market Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch